ORLANDO, Ambrogio
 Distribuzione geografica
Continente #
NA - Nord America 738
EU - Europa 135
AS - Asia 57
Totale 930
Nazione #
US - Stati Uniti d'America 736
IT - Italia 53
CN - Cina 33
DE - Germania 18
FI - Finlandia 14
SG - Singapore 10
GB - Regno Unito 9
IE - Irlanda 6
IN - India 6
UA - Ucraina 6
RO - Romania 5
RU - Federazione Russa 5
SE - Svezia 5
CH - Svizzera 4
FR - Francia 4
BE - Belgio 3
TR - Turchia 3
CA - Canada 2
HK - Hong Kong 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
IL - Israele 1
KR - Corea 1
Totale 930
Città #
Fairfield 112
Ashburn 90
Chandler 76
Houston 76
Woodbridge 66
Seattle 47
Wilmington 44
Ann Arbor 38
Cambridge 34
Palermo 19
Des Moines 17
Altamura 12
Medford 11
Dearborn 8
Lawrence 8
Princeton 8
Singapore 7
Bremen 6
Dublin 6
Nanjing 6
Boardman 5
New York 5
Beijing 4
Falls Church 4
Hebei 4
Jacksonville 4
Jiaxing 4
Jinan 4
Kumar 4
London 4
Ludwigshafen am Rhein 4
San Diego 4
Zurich 4
Brussels 3
Izmir 3
Phoenix 3
Shenyang 3
Atlanta 2
Chicago 2
Hong Kong 2
Los Angeles 2
Milan 2
Saint Petersburg 2
San Paolo di Civitate 2
Tulsa 2
Venice 2
Acton 1
Amsterdam 1
Auburn Hills 1
Changsha 1
Charlotte 1
Den Haag 1
Esslingen am Neckar 1
Fuzhou 1
Hangzhou 1
Helsinki 1
Kilburn 1
Lanzhou 1
Mehlingen 1
Mumbai 1
Pune 1
Seongnam 1
Shanghai 1
Southwark 1
Taiyuan 1
Taizhou 1
Tel Aviv 1
Tianjin 1
West Chicago 1
Totale 798
Nome #
Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease 157
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease 148
A. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease. 137
Letter: psoriasiform eruption during vedolizumab therapy 133
Toxic megacolon and human Cytomegalovirus in a series of severe ulcerative colitis patients 121
Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease 105
Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study 95
ATG16L1 contribution to Crohn's disease risk in Sicily 78
null 3
Totale 977
Categoria #
all - tutte 3.464
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020349 32 14 19 42 33 75 32 22 36 13 21 10
2020/2021129 9 8 2 26 1 0 2 16 8 27 5 25
2021/202297 2 12 7 5 5 5 3 9 11 11 11 16
2022/2023183 14 40 3 24 20 30 13 16 14 1 5 3
2023/2024100 6 13 1 7 10 13 20 7 0 3 3 17
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 977